Upcoming Medical Conferences in Boston

Academy of Laser Dentistry (ALD) Standard Proficiency Certification Course is organized by Full Spectrum Seminars and will be held during Jun 22 - 23, 2018 at Tufts University, Boston, Massachusetts, United States of America. Additional details will be posted as soon as they are available.

Hands-On Course with Multiple Hard- and Soft-Tissue Lasers is organized by Tufts University School of Dental Medicine and will be held during Jun 22 - 23, 2018 at Tufts University School of Dental Medicine, Boston, Massachusetts, United States of America. The target audience for this medical event is Dentists. This CME Conference has been approved for a maximum of 13 Credit Hours. Course Description: This program is the worldwide accepted standard of minimal laser training for those who use lasers in practice. The curriculum is the Standard Proficiency Course according to the Academy of Laser Dentistry. The program consists of 4 parts: Didactic, Clinical hands-on experience, a practical clinical examination and the Online Written Examination administered by the Academy of Laser Dentistry Learning Objectives are: • Gain a basic understanding of the science of laser physics • Learn about laser safety and the potential issues that may arise with their use • Gain a thorough knowledge of all available laser wavelengths and their applications for dentistry • Become familiar with laser-tissue interractions. Additional details will be posted as soon as they are available.

Inaugural AACR International Meeting - Advances in Malignant Lymphoma: Maximizing the Basic-Translational Interface for Clinical Application is organized by American Association for Cancer Research (AACR) and will be held during Jun 22 - 26, 2018 at Boston Marriott Copley Place, Boston, Massachusetts, United States of America. This CME Conference has been approved for a maximum of 27.75 AMA PRA Category 1 Credits. Conference Description : The program was designed to take advances in basic research areas and discuss how those are being applied, or have the potential to be applied for the betterment of patients in the clinic. Physician-scientists and clinicians will leave this program with new knowledge in the fields of gene editing, liquid biopsies, precision medicine trial design, early disease detection, and immunotherapy. Conference Objectives are : • Articulate the potential advantages, challenges, and limitations of CAR-T cell therapy for Non-Hodgkin Lymphoma. • Provide an overview of the opportunities and challenges facing the implementation of liquid biopsies as an alternative to tissue biopsies for clinical decision making. • Explain how clonal dynamics and tumor heterogeneity affect clinical outcome. • Evaluate the potential for lymphoma MATCH trials and provide rationale or support for this approach. Additional details will be posted as soon as they are available.

Lifestyle Medicine: Tools for Promoting Healthy Change is organized by Harvard Medical School (HMS) and will be held during Jun 22 - 23, 2018 at Renaissance Boston Waterfront Hotel, Boston, Massachusetts, United States of America. The target audience for this medical event is Physicians, Nurse Practitioners, Physician Assistants, Nurses, Psychologists, Social Workers, Dietitians, Educators, Health Coaches, Physical Therapists, Occupational Therapists, Residents, Fellows. This CME Conference has been approved for a maximum of 29.25 AMA PRA Category 1 Credits. State-of-the-Art Approaches to Help Patients Initiate and Sustain Health-Promoting Behaviors This immersive, two-day Harvard Medical School CME course offers state-of-the-art strategies to guide patients to healthier lives. Education includes evidence-based strategies, tools, and techniques to effect healthier changes in patients (and ourselves), including nutrition, exercise, sleep, weight loss, and stress management. This course also provides updates on payment structures that reward clinicians based on patients’ health behaviors and health outcomes. This course has sold out each of the past 3 years. Past participants report a renewed passion for practicing medicine and reduced personal stress as they themselves learn to enhance their own health and to serve as role models for their patients. Course Description : According to the World Health Organization, by 2020, two-thirds of all disease worldwide will be the result of lifestyle choices. Currently, the leading causes of death in the United States are lifestyle related: poor diet, lack of exercise, obesity, tobacco use, and overconsumption of alcohol. This course is designed to change your competence and performance-in-practice by increasing your knowledge of Lifestyle Medicine and helping you develop strategies to incorporate it into patient care, providing the newest science of nutrition, physical activity, and management skills. The course will focus on effectively counseling your patients to improve their overall lifestyle, including stress management, diet, and exercise. You will also have the opportunity to commit to improving your personal health practices so that you can serve as a better role model for your patients. Reasons to Attend in 2018 : Highlights of the 2018 program include: • The strategies that produce the best results for stress resiliency, sleep quality, nutrition, and weight-loss counseling • Guidance to prescribe exercise and perform risk assessments • Health coaching (it’s not “eat less; exercise more”) • Clinician self-care: what it is and why it matters • What really gets patients (even reluctant ones) to make healthy changes • Leveraging lifestyle medicine to prevent and treat type 2 diabetes, hypertension, high cholesterol, depression, anxiety, osteoporosis, dementia, certain cancers, and sexual health issues • When, why, and how to incorporate lifestyle medicine for underserved populations • Pre-and post-course workshops on Motivational Interviewing and Culinary Medicine Learning Objectives : Upon completion of this course, participants will be able to: • Recognize that lifestyle choice are the root cause of the majority of disease, death, and healthcare cost. • Utilize evidence-based practices in health coaching to support initial behavior change and to sustain the new behavior. • More effectively and efficiently counsel patients on the importance of lifestyle changes. • Develop strategies to encourage patients to make and meet their new lifestyle goals. Skills Advancement and Networking : Recognized experts in the fields of lifestyle medicine, behavior change, health coaching, exercise, stress management, and nutrition provide guidance and innovations for: • Incorporating lifestyle medicine into your current practice • Improving patient communication and motivational interviewing • Building an effective lifestyle medicine team • Engaging resistant patients • Safely and effectively prescribing exercise or increased physical activity • Persuasively approaching nutrition counseling • Efficiently navigating the changing insurance landscape You are actively encouraged to pose questions to and network with faculty as well as with fellow participants-like-minded health professionals who are seeking to promote lifestyle medicine as their practice pattern. Additional details will be posted as soon as they are available.

Thoracic Pathology Course is organized by Harvard Medical School (HMS) and will be held during Jun 22 - 24, 2018 at Massachusetts General Hospital, Boston, Massachusetts, United States of America. The target audience for this medical event is Pathologists, Thoracic Pathologists, Specialty Physicians, Nurse Practitioners, and Physician Assistants. This course may also be of interest to those who practice in Oncology and Hematology, Pathology, Pulmonary Medicine, and Radiology and Nuclear Medicine. This CME Conference has been approved for a maximum of 18.50 AMA PRA Category 1 Credits. Course Description : This course, codirected by Dr. Mino-Kenudson at Massachusetts General Hospital, Boston, and Dr. William Travis at Memorial Sloan Kettering Cancer Center, New York, presents a broad over-view of thoracic pathology with clinical correlation. It has been sponsored by Massachusetts General Hospital and Memorial Sloan Kettering Cancer Center. The faculty consists of thoracic pathologists, molecular pathologists, thoracic radiologists, thoracic surgeons and thoracic oncologists from Massachusetts General Hospital, Brigham and Women’s Hospital, Memorial Sloan Kettering Cancer Center and other academic medical centers who have known expertise in the specific subject matter areas. The course is designed to update both academic practicing pathologists and those in the community with new advances in surgical pathology and relevant molecular pathology and to provide aids in diagnosis based on conventional morphologic analysis as well as updates on new techniques such as immunohistochemistry and molecular analyses to the extent that they bear on the establishing the correct diagnosis. The program features conventional didactic lectures with frequent discussion periods and case-based presentations with extensive time for one-on-one contact with faculty. Learning Objectives : Upon completion of this activity, participants will be able to: • Evaluate individual tests and their tissue requirements for clinical management of advanced lung cancer patients • Apply the updated staging guidelines for lung cancer • Analyze current diagnostic criteria for Mesothelioma, including a clinicopathological staging system • Determine when to apply the AHRQ Guideline for the care of patients with Interstitial Lung Disease Additional details will be posted as soon as they are available.

3rd International Conference on Integrative Medicine: Role of Yoga and Ayurveda In Cancer & Palliative Care is organized by Indo US Health Initiative (IUHI), Inc, Institute of Advanced Sciences (INADS), Swami Vivekananda Yoga Anusandhan Samsthana (S-VYASA), Benson-Henry Institute (BHI) for Mind Body Medicine and will be held during Jun 22 - 23, 2018 at Joseph B. Martin Conference Center, Boston, Massachusetts, United States of America. Conference Description : Integrative Medicine : Integrative medicine is grounded in the definition of health. The World Health Organization (WHO) defines health as “a state of complete physical, mental and social well being and not merely the absence of disease or infirmity.” Patient-centered care is the core belief of integrative medicinal approach and addresses the full range of physical, emotional, mental, social, spiritual and environmental influences that affect a person’s health. Employing a personalized strategy that considers the patient’s unique conditions, needs, and circumstances, it uses the most appropriate interventions from an array of disciplines to heal illness and disease as well as regain and maintain optimum health. Through personalizing care, integrative medicine goes beyond the treatment of symptoms to address all the root causes of an illness. In doing so, the patient’s immediate health needs, as well as the effects of the long-term and complex interplay between biological, behavioral, psycho-social and environmental influences, are taken into account. With a growing demand in the field of Integrative medicine, it can be considered a global priority in the research and development of long-term, cost-effective medical care, and disease management. Ayurveda and Yoga : Ayurveda and Yoga are systems that approach an individual as a microcosm considering all aspects of their being such as their diet, lifestyle, relationships, mental health, spirituality, and environment and assessing its influence on the quality of life and happiness. Both systems originate from the Indian subcontinent and have been proven to reduce pain, heal the root causes and also help rehabilitation for those who are suffering from over-use or addiction. Yoga has become mainstream and is widely utilized for therapeutic yield specifically in the management of pain. Ayurveda has long employed natural resources for the reduction or curative effect in various ailments resulting in acute to chronic pain. The purpose of this symposium is to address the solutions to these key issues to transform the healthcare of the emerging world with integrative approach bringing ancient systems of Yoga and Ayurveda and modern medicine together via research and development and proper education. Additional details will be posted as soon as they are available.

Drug Information Association / Develop Innovate Advance (DIA) Global Annual Meeting 2018 is organized by Drug Information Association/Develop Innovate Advance (DIA) and will be held during Jun 24 - 28, 2018 at Boston Convention and Exhibition Center, Boston, Massachusetts, United States of America. This CME Conference has been approved for a maximum of 17.50 AMA PRA Category 1 Credit. Learning Objectives: At the conclusion of DIA 2018, participants should be able to: • Compare the current regional regulatory and public policy environment pertaining to pharmaceuticals and related products • Discuss the regulatory and economic factors that impact the global biopharmaceutical industry • Recognize the challenges facing regulatory agencies and industry in research study design and statistical methodology in preclinical and clinical development • Identify relevant data, document and systems standards, and integration approaches for medical product development and explain their impact on quality and end-to-end efficiency in data collection, management, submission, and approval processes • Describe the current and future scope of innovative technology, including wearables and other mobile devices, in the generation and collection of electronic source data in clinical research and postmarket assessment to improve patient outcomes • Discuss the role of big data and analytics, approaches and methodologies for their application throughout the product lifecycle, and legal, privacy, and security implications for their use • Discuss the role of Real World Evidence (RWE) in medical product development and throughout the product lifecycle • Identify challenges and emerging standards and methodologies to ensure the appropriate use of real-world data in developing evidence for regulatory decision-making and lifecycle applications • Identify legal, advertising, and marketing issues related to providing product information • Apply principles of risk assessment and management to development and post-market phases of new healthcare products • Summarize issues in safety reporting and data analysis regarding adverse events • Distinguish regional approaches to integration of evidence-based medicine and comparative effectiveness research into healthcare decision-making • Describe current issues in designing and implementing clinical trials, including patient recruitment, site selection, and management of multi-regional clinical trials • Discuss the evolving role of medical affairs and scientific communications in the medical product development landscape • Identify current opportunities and challenges in the area of personalized medicine for disease treatment • Examine ways to provide appropriate support to the clinical trial process that will ultimately impact patient care • Examine the challenges and opportunities in assessing medical product value and access to medicines • Describe meaningful engagement of patients with sponsors, regulators, and other stakeholders throughout the medical product lifecycle • Identify policies, practices, and resources to ensure integration of the patient voice in decision-making throughout the lifecycle • Interpret and apply quality standards, regulations, and guidelines for medical product development and lifecycle management to ensure that products are safe, efficacious, and available to patients who need them Additional Details will be posted as soon as they are available.

Biologics & Biosimilars Congress is organized by Global Engage Ltd and will be held during Jun 25 - 26, 2018 at Hilton Boston Back Bay, Boston, Massachusetts, United States of America. Course Description: Designed for experts working in a variety of exciting areas in biological therapeutics this conference will provide in-depth studies of antibody-based therapies, advances in immunotherapy and immuno-oncology, as well as developments in protein biotherapeutic considerations, techniques and technologies. Alongside this, our Biosimilars session will provide an opportunity to discuss the latest in the regulatory and commercial landscapes and a forum to examine the next steps in this ever-developing sector. Designed for industry experts, this congress examines the latest advances in antibody technology, immunotherapies-cells, and protein biotherapeutic considerations, as well as a space to keep up to date with recent developments in the world of biosimilars. With a strong focus on antibody based therapeutics, tracks 1 and 2 provide industry leaders with the opportunity to present updates on their strategy, pipeline and existing candidates in a variety of areas including antibody discovery and design, immuno-oncology, bispecific antibodies and antibody-drug conjugates. Other talks in these tracks will examine checkpoint inhibitor therapies and recent innovations in the exciting area of T-Cell therapeutics, as well as the opportunity to follow developments in fusion proteins, novel scaffolds and immunogenicity considerations across protein biotherapeutics. The Biosimilars track explores themes of similarity, regulation and public perception, nalongside presentations on candidate generics in various stages of development. Executive panels and roundtables will foster discussion on the direction of the field, and the approaches required to ensure that the industry continues to flourish. Additional details will be posted as soon as they are available.

Evaluating and Treating Pain is organized by Harvard Medical School (HMS) and will be held during Jun 25 - 29, 2018 at The Fairmont Copley Plaza Hotel, Boston, Massachusetts, United States of America. The target audience for this medical event is Pain Specialists, Anesthesiologists, Physiatrists, Psychiatrists, Internists, Family Physicians, Neurologists, Palliative Care Physicians, Oncologists, Orthopedists, Emergency Medicine Specialists, Nurse Practitioners, Nurse Anesthetists, Physician Assistants, Dentists, Psychologists, Pharmacists and other healthcare professionals interested in the practice of alleviating pain. This CME Conference has been approved for a maximum of 52.75 AMA PRA Category 1 Credits. Course Description : A significant amount of research has indicated that many, if not all, types of pain are undertreated. Some data indicate that only 25% of patients treated for pain receive adequate relief. In addition, several studies have shown that various pain-relieving techniques may be used inappropriately, which can result in patient harm. Evaluating and Treating Pain is a live course held each spring in Boston. It provides a comprehensive review and update of the basic science and advances in the field of pain medicine. The faculty consists of specialists in many aspects of pain medicine including anesthesiology, neurology, psychiatry and psychology, internal medicine, physical medicine and rehabilitation, orthopedic surgery, interventional radiology, and neurosurgery. Participants learn how to diagnose common pain problems and explore various options for treatment of chronic pain, acute pain, and cancer-related pain. Pharmacologic, behavioral and interventional treatments of pain will be discussed. Learning Objectives : Upon completion of this course, participants will be able to: • Determine which patients are optimal to receive pharmacological treatment of pain with opioids and other medications and titrate the doses appropriately • Determine which patients should receive interventional pain treatments such as injection therapies and implanted devices • Use a variety of pain-relieving techniques to assure adequate pain control in clinical practice • Recognize when to use mind/body techniques in practice to help your patients with chronic or debilitating pain • Apply current guidelines for the management of pediatric pain • Assess effective ways in which to manage end-of-life pain Additional details will be posted as soon as they are available.

Emerging Women Executives in Health Care is organized by Harvard T.H. Chan School of Public Health Executive and Continuing Professional Education (ECPE) and will be held during Jun 25 - 28, 2018 at Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America. The target audience for this medical event is senior women executives from around the world from hospitals, hospital systems, physician practices, insurance companies, pharmaceutical companies, medical device companies, ministries of health, health care foundations, and other healthcare-related organizations, including: • Executives, senior vice presidents, vice presidents, assistant vice presidents, department directors, and other executives reporting to the c-suite or senior vice president level • Medical directors, clinical chiefs of service, and other senior managers who have responsibility for planning, allocating resources, managing staff, and developing policy • Women leaders in compliance, human resources, communications, marketing, operations, or other administrative functions Course Description : This healthcare leadership development program for women is designed to provide you with both the knowledge and the skills you need to face the challenges of leading complex healthcare organizations. This program provides women leaders with the opportunity to be in a classroom among female executives from around the world and focuses on helping women in senior positions develop effective leadership strategies to improve organizational performance. Learning Objectives are: The Women Executives in Health Care program is designed to engage women leaders in further developing the knowledge, skills, and abilities necessary to effectively lead complex healthcare organizations. As a participant in this program, you will: • Acquire the knowledge needed to create an institutional vision and a supporting, achievable strategic plan. • Develop a deeper awareness of personal leadership and management styles in order to better manage conflict and engage in productive difficult conversations. • Enhance your capacity to lead sustainable change. • Learn to negotiate productive alliances and partnerships. • Understand individual motivation, team dynamics, and how to lead teams effectively. Additional details will be posted as soon as they are available.